17/09/2021
Surface Oncology | +18.14% |
Magenta Therapeutics | +13.39% |
Fulcrum Therapeutics | +11.34% |
I Mab | +11.31% |
Calithera Biosciences Inc | +10.73% |
Protagonist Therapeutics | -62.00% |
Tcr2 Therapeutics | -36.45% |
Generation Bio | -7.54% |
Altimmune | -7.07% |
Syros Pharma | -6.79% |